GOLDMED SUISSE S.A.
Is a pioneer in advanced healthcare innovation, marrying Swiss manufacturing excellence with cutting-edge botanical research. We are dedicated to engineering uncompromising, eco-clinical medical devices and food supplements based on natural extracts and bio-based active molecules that meet the rigorous standards of the world’s most prestigious healthcare institutions.
The Genesis of Eco-Clinical Recovery
Bridging Botanical Integrity with Clinical Precision in Advanced Dermatological & Wound Care
For centuries, medical institutions have sought the purest, most efficacious treatments for patient care. GOLDMED SUISSE S.A. introduces a paradigm shift in dermatological and wound recovery that completely departs from obsolete, petroleum-derived ointments.
The Source of Our Efficacy: Proprietary Cultivation & R&D - Food Supplement
The foundation of our entire product ecosystem stems from a dedicated R&D program initiated in 2018. This foundational research focused on the cultivation and manufacturing of OPHENOIL—our high-phenolic, premium Extra Virgin Olive Oil.
- Proprietary Origins: OPHENOIL is produced exclusively from olives harvested at our own proprietary orchard in the mid-central region of Abruzzo, Italy, and holds strict Organic Certification by Bureau Veritas.
- Internationally Validated: Its unparalleled quality has been recognized with Gold Medals at the NYIOOC (New York), Olive Japan (Tokyo), Los Angeles (USA and Dubai Olive Oil Competitions.
- OPHENOIL Longevity: As a direct consequence of this foundational agricultural R&D, we developed our premium food supplement. OPHENOIL Longevity is based on our high-phenolic EVOO and is powerfully enriched with natural Oleocanthal, meticulously extracted from the EVOO itself, OLIGEN, manufacturer by OLEOLIVE (USA).
Advanced Medical Devices: YR1973, YR1977
Building upon the success of our source materials, we engineered the YR1973 and YR1977, Medical Device Lines—a bio-active lipidocolloid matrix designed for strict ecological compliance.
Our proprietary clinical engine for these devices is powered by OLIGEN™, a highly purified phenolic extract derived directly from olive oil, only.
Uncompromising Scientific Discovery
Our clinical innovations are backed by exhaustive research developed alongside Italy’s most prestigious academic and medical institutions:
- Green Extraction Technology: In collaboration with the University of Florence’s PHYTOLAB Center, we mapped the precise extraction and stabilization of these active molecules using sustainable green technology.
- Proven In-Vivo Efficacy: Clinical trials conducted at Policlinico Tor Vergata (Rome) demonstrated that our specific high-phenolic formulations significantly reduce systemic oxidative stress and inflammation.
- Peer-Reviewed Foundations: Our underlying science is validated by international medical literature, including groundbreaking in-vivo pilot studies and research published in Nutrients (2019) and Molecules (2020).
Regulatory Clarity & Safety
The YR1973 and YR1977 lines are strictly classified and registered as Substance-Based Medical Devices under the EU Medical Device Regulation (MDR). They are not classified as pharmaceutical-grade drugs; rather, they achieve their primary intended action through highly effective physical means—specifically, barrier protection and micro-environment management—ensuring safe, natural, and advanced recovery.
